Development and validation of the Exercise-Induced Laryngeal Obstruction Dyspnea Index (EILODI)

Exercise-induced laryngeal obstruction (EILO) causes exertional dyspnea and is important for its effect on quality of life, diagnostic confusion with exercise-induced asthma, and health care resource utilization. There is no validated patient-reported outcome measure specific to EILO. We sought to d...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 149; no. 4; pp. 1437 - 1444
Main Authors Olin, James Tod, Shaffer, Monica, Nauman, Emily, Durso, Catherine S., Fan, Elizabeth M., Staudenmayer, Herman, Christopher, Kent L., Gartner-Schmidt, Jackie
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Exercise-induced laryngeal obstruction (EILO) causes exertional dyspnea and is important for its effect on quality of life, diagnostic confusion with exercise-induced asthma, and health care resource utilization. There is no validated patient-reported outcome measure specific to EILO. We sought to develop, validate, and define a minimal clinically important difference for a patient-reported outcome measure to be used with adolescents and young adults with EILO. A multidisciplinary group created a preliminary measure, modified by a 10-member participant focus group, with 20 items scored along a 5-point Likert scale. A subsequent cohort of participants recruited from a clinic, aged 12 to 21 years, with confirmed EILO by continuous laryngoscopy during exercise testing (1) completed the measure at 3 points in time over 28 days and (2) provided anchoring data in the form of a daily exercise log and categorical self-assessments of clinical improvement. Thirty additional participants without exertional dyspnea served as controls. Two hundred nineteen subjects with mild to severe EILO participated in the exploratory factor analysis, which identified 7 factors within the preliminary outcome measure. After a process of item reduction, a 12-item metric with a total score ranging from 0 to 48 was developed. Mean scores of patients with EILO and healthy controls at baseline were 28.8 ± 7.4 and 4.5 ± 7.4, respectively. A minimal clinically important difference of 6 was determined by comparison of index change with changes in categorical self-assessments of improvement. This is the first patient-reported outcome measure specifically designed for adolescents and young adults with EILO.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0091-6749
1097-6825
1097-6825
DOI:10.1016/j.jaci.2021.09.027